ADR Report-Foreign stocks flat, but commodity ADRS hurt LatAm
By Rodrigo Campos
NEW YORK, June 17 (Reuters) - Overseas shares traded in the United States were flat on Wednesday as rising defensive stocks, including drugmakers, offset declines in energy and basic materials companies.
Advancers included the U.S.-listed shares of AstraZeneca (AZN.N: Quote, Profile, Research) and Novartis AG (NVS.N: Quote, Profile, Research), up more than 2 percent each, while in telecommunications, another traditionally defensive sector, the ADRs of Vodafone VOD.N gained 3.4 percent and those of Deutsche Telekom (DT.N: Quote, Profile, Research) jumped 4.3 percent.
But many basic materials and energy companies fell despite an 0.8 percent gain in U.S. crude oil futures CLc1, as prospects for a sluggish global economic recovery worried investors about a decrease in demand.
Brazilian energy giant Petrobras (PBR.N: Quote, Profile, Research) fell 2 percent to $40.28 while miner Vale (VALE.N: Quote, Profile, Research) lost 1.1 percent to $18.60, which helped push the Bank of New York Mellon's index of leading American Depositary Receipts down 1.1 percent.
The broader Bank of New York Mellon index of leading ADRs dipped 0.01 percent, compared with a decline of 0.09 percent in the Dow Jones industrial average .DJI and a drop of 0.14 percent in the benchmark Standard & Poor's 500 index .SPX.
The Bank of New York Mellon's index of leading Asian ADRs rose 0.2 percent, with outstanding gains coming from Japanese financial companies, including Mizuho Financial Group (MFG.N: Quote, Profile, Research), up 4 percent at $5.17.
The bank's index of leading European ADRs inched up 0.03 percent. (Editing by Jan Paschal)
© Thomson Reuters 2009. All rights reserved. | Learn more about Thomson Reuters
